RAMICOR 2,5 MG tablett Estland - Estlands - Ravimiamet

ramicor 2,5 mg tablett

hexal ag - ramipriil - tablett - 2,5mg 30tk; 2,5mg 28tk; 2,5mg 60tk; 2,5mg 10tk; 2,5mg 50tk; 2,5mg 20tk; 2,5mg 250tk; 2,5mg 100tk

AMPRIL 10 MG tablett Estland - Estlands - Ravimiamet

ampril 10 mg tablett

krka, d.d., novo mesto - ramipriil - tablett - 10mg 50tk; 10mg 60tk; 10mg 10tk; 10mg 30tk

RAMIGAMMA tablett Estland - Estlands - Ravimiamet

ramigamma tablett

woerwag pharma gmbh & co. kg - ramipriil - tablett - 5mg 10tk; 5mg 28tk; 5mg 100tk; 5mg 14tk; 5mg 98tk; 5mg 20tk; 5mg 30tk; 5mg 42tk

AMPRIL 5 MG tablett Estland - Estlands - Ravimiamet

ampril 5 mg tablett

krka, d.d., novo mesto - ramipriil - tablett - 5mg 60tk; 5mg 100tk; 5mg 90tk; 5mg 20tk; 5mg 50tk

AMPRIL 2,5 MG tablett Estland - Estlands - Ravimiamet

ampril 2,5 mg tablett

krka, d.d., novo mesto - ramipriil - tablett - 2,5mg 60tk; 2,5mg 50tk; 2,5mg 90tk; 2,5mg 20tk; 2,5mg 30tk; 2,5mg 10tk; 2,5mg 100tk

RAMIGAMMA tablett Estland - Estlands - Ravimiamet

ramigamma tablett

woerwag pharma gmbh & co. kg - ramipriil - tablett - 10mg 28tk; 10mg 30tk; 10mg 42tk; 10mg 98tk; 10mg 50tk; 10mg 100tk; 10mg 10tk

RAMIGAMMA tablett Estland - Estlands - Ravimiamet

ramigamma tablett

woerwag pharma gmbh & co. kg - ramipriil - tablett - 2,5mg 42tk; 2,5mg 20tk; 2,5mg 30tk; 2,5mg 28tk; 2,5mg 10tk; 2,5mg 98tk; 2,5mg 50tk

CARDACE tablett Estland - Estlands - Ravimiamet

cardace tablett

sanofi winthrop industrie - ramipriil - tablett - 10mg 30tk; 10mg 45tk; 10mg 100tk; 10mg 500tk; 10mg 10tk; 10mg 300tk; 10mg 15tk; 10mg 14tk; 10mg 7tk

RAMICOR 10 MG tablett Estland - Estlands - Ravimiamet

ramicor 10 mg tablett

hexal ag - ramipriil - tablett - 10mg 60tk; 10mg 30tk; 10mg 20tk; 10mg 100tk; 10mg 250tk; 10mg 28tk

Lyxumia Europese Unie - Estlands - EMA (European Medicines Agency)

lyxumia

sanofi winthrop industrie - liksisenadiidi - suhkurtõbi, tüüp 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.